What is Tobramycin?
Category: Prescription Drugs
Most popular types: TOBI TOBI Podhaler Tobramycin ophthalmic Show all
Tobramycin is an antibiotic used for susceptible gram-negative bacilli; topically for susceptible eye infections; as an inhalant it is used for management of Pseudomonas aeruginosa in cystic fibrosis patients.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Cystic fibrosis | 74 | 11 | |
| Bronchiectasis | 42 | 6 | |
| Prevent infection | 2 | 0 | |
| Doctor recommendation | 1 | 0 | |
| Kartagener syndrome | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 1 | |
| Mild | 3 | |
| None | 22 |
Commonly reported side effects and conditions associated with Tobramycin
| Side effect | Patients | Percentage |
|---|---|---|
| Bronchospasm | 1 | |
| Dizzy spells | 1 | |
| Hoarseness | 1 | |
| Ringing in ears (tinnitus) | 1 |
Why patients stopped taking Tobramycin
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 9 | |
| Side effects too severe | 4 | |
| Did not seem to work | 3 | |
| Other | 3 | |
| Change in health plan coverage | 1 | |
| Doctor's advice | 1 | |
| Personal research | 1 |
Duration
Stopped taking Tobramycin
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 5 | |
| 1 - 6 months | 1 | |
| 2 - 5 years | 4 | |
| 5 - 10 years | 4 | |
| 10 years or more | 2 |
What people switch to and from
Patients started taking Tobramycin after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Tobramycin (TOBI) | 1 |
Patients stopped taking Tobramycin and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| ceftazidime | 1 | |
| Colistin sulphate (Colomycin) | 1 | |
| Tobramycin (TOBI) | 1 |
Last updated: